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Abstract
Background:  Tissue microarray (TMA) technology has been developed to facilitate large,
genome-scale molecular pathology studies. This technique provides a high-throughput method for
analyzing a large cohort of clinical specimens in a single experiment thereby permitting the parallel
analysis of molecular alterations (at the DNA, RNA, or protein level) in thousands of tissue
specimens. As a vast quantity of data can be generated in a single TMA experiment a systematic
approach is required for the storage and analysis of such data.
Description:  To analyse TMA output a relational database (known as TmaDB) has been
developed to collate all aspects of information relating to TMAs. These data include the TMA
construction protocol, experimental protocol and results from the various immunocytological and
histochemical staining experiments including the scanned images for each of the TMA cores.
Furthermore the database contains pathological information associated with each of the specimens
on the TMA slide, the location of the various TMAs and the individual specimen blocks (from which
cores were taken) in the laboratory and their current status i.e. if they can be sectioned into further
slides or if they are exhausted. TmaDB has been designed to incorporate and extend many of the
published common data elements and the XML format for TMA experiments and is therefore
compatible with the TMA data exchange specifications developed by the Association for Pathology
Informatics community. Finally the design of the database is made flexible such that TMA
experiments from several types of cancer can be stored in a single database, which incorporates
the national minimum data set required for pathology reports supported by the Royal College of
Pathologists (UK).
Conclusion: TmaDB will provide a comprehensive repository for TMA data such that a large
number of results from the numerous immunostaining experiments can be efficiently compared for
each of the TMA cores. This will allow a systematic, large-scale comparison of tumour samples to
facilitate the identification of gene products of clinical importance such as therapeutic or prognostic
markers. In addition this work will contribute to the establishment of a standard for reporting TMA
data analogous to MIAME in the description of microarray data.
Background
Tissue microarray technology provides a high-throughput
method for large-scale immunohistochemical analyses
under uniform experimental conditions. The TMA
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technology was developed to assist genome-scale molecu-
lar pathology studies and facilitate the analysis of molec-
ular alterations in thousands of tissue specimens in
parallel at the DNA, RNA, or protein level [1]. TMAs are
constructed by drilling 0.6 mm cylindrical cores at the site
of interest from various paraffin-embedded specimen
blocks, referred to as donor blocks, and re-embedding
them into an empty paraffin block, referred to as recipient
block (Figure 1).
On a single TMA block up to 1000 specimens can be
arrayed representing a number of different pathologies
and tissue types both, normal and tumour. The recipient
block is then sectioned off into a number of slides (from
50 – 400) [3]. These slides can then be screened at the
DNA, RNA and protein level by fluorescence in situ
hybridisation (FISH), in situ hybridisation (ISH), and
immunohistochemistry (IHC), respectively.
There is a large quantity of data associated with a TMA
experiment. These include images, quantified experimen-
tal results, patient demographics and pathology reports of
each specimen [4]. The vast quantity of data generated by
TMA experiments and the different types of information
associated with each experiment has led to the need for a
central data repository. Thus far there have only been
three papers published on approaches for the archiving
and analysis of TMA data and all three have limitations
[5,6]. The relational database management system of
Manley et al. [5] associates pathology data with immuno-
histochemical staining results but is restricted to just one
type of cancer in this case being prostate cancer and can-
not be adapted to include pathology data from different
types of cancer. Liu et al. [6] on the other hand focus on
the archiving and the analysis of TMA staining results but
offer no means to relate the pathology information.
Finally, the TAD database developed by Coombes et al. [7]
Schematic representation of the construction of a TMA block Figure 1
Schematic representation of the construction of a TMA block. TMAs are assembled by extracting cylindrical cores (using a 0.6 
mm needle) from specific locations in the paraffin-embedded tissue blocks "donor" and re-embedded in an empty paraffin block 
"recipient" [2]. The TMA block is then sectioned off onto slides.
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is a tool focusing on enabling pathologists to solely score
cores on TMA slides generated from a single TMA block. It
is therefore considered too restrictive as a database for
archiving TMA data.
Currently there are no central databases that facilitate the
storage and analysis of TMA data that can also accommo-
date pathological information from different types of can-
cer. This has led to the design and implementation of
TmaDB a relational database that archives all aspects of
TMA data into a single database that can be accessed from
remote locations to both update and retrieve data. The
database design is flexible, thus incorporating pathologi-
cal information from different types of cancer into one
central database. The database design is compliant with
recently recommended data exchange specifications [4,8].
Construction and contents
The relational database is implemented in MySQL server
version 14.5. The database schema was designed by
Entity-Relationship (ER) modelling (Figure 2) and can be
found on the TmaDB Web site.
The "block" table is the key table in the database to which
all other tables are related (directly or indirectly). This
table contains the specimen identifier and other data
relating to a particular specimen. The "path_report" table
is another important table that stores some generic infor-
mation about a patients' medical history regardless of the
specific cancer diagnosis. The specific information associ-
ated with a particular type of cancer is stored in the dis-
ease-specific tables. The disease specific information is
obtained from the national minimum data set required
for the reporting of cancer pathological investigations.
Entity relation (ER) diagram of TmaDB Figure 2
Entity relation (ER) diagram of TmaDB.BMC Bioinformatics 2005, 6:218 http://www.biomedcentral.com/1471-2105/6/218
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This minimum data set is a standard supported by the
Royal College of Pathologists. The "tma" table stores the
information about the design and the construction of the
TMA block (also referred as the recipient block), which
can then be sectioned onto several slides (Figure 1). Each
of these slides is stained with a specific antibody or a his-
tochemical stain. The staining protocol, the slide image
and other details of the experiment are stored in the
"tma_experiment" table. Each of the cores on the TMA
slide has a stain result and a scanned image associated
with it that is stored in the "core_expt_results" table.
Other information regarding the quality of the core and
the tissue diagnosis is stored in the "core_info" table. The
"whole_tissue_section" table stores the staining protocol
as well as the results and the images of the stain generated
from the traditional whole tissue section (if available) for
the clinical specimens used in the TMA.
Content
The data submitted to the database comes from a number
of different sources. One of the data sources is the pathol-
ogy report for each clinical specimen, which is sent with
the specimen either directly from the hospital, or pro-
vided as part of the clinical trials. These reports are usually
provided as paper copies in the form of a letter. If sent as
a paper copy, they are digitised by an individual who then
extracts the information that would be required for the
national minimum data set for each of the specific types
of cancer (Figure 3). The national minimum data set for
reporting specific types of cancer is supported by the Royal
College of Pathologists and the forms can be downloaded
from the Royal College of Pathologists website http://
www.rcpath.org/. This information can be entered directly
on the Web to be assimilated into the database or saved as
a tab delimited text file that can be uploaded from the
Web site. Most of the information obtained is stored in
the "path_report", "patient" and "block" tables (Figure 2).
It should be noted that patients' names and addresses are
not stored in the database.
Information on the storage location in the laboratory of
each block and whether the block is still in use is stored in
the block table along with when this information was last
updated. This enables a block to be found easily in the
event it is required for future experiments. This informa-
tion is uploaded from the tab delimited text file contain-
ing details of TMA construct design. The information
recorded in this file is shown on the Web site, and can be
downloaded and used as a template for recording data
alongside experimental work.
The pathological details of each of the cores together with
additional information such as the location on the origi-
nal block from which the core was obtained and the qual-
ity of the core are uploaded from a tab delimited text file
and stored in the core location table. The TMA slide
immunohistological staining protocol and the results are
also recorded in a tab delimited text file, an example of
which is shown as a template on the Web site.
Each TMA slide is scanned using software that provides a
very high-resolution image of the TMA slide enabling
users to "zoom in" and "zoom out" on the image over the
web. TMA slide images are saved on an image server. They
can be divided into a grid such that each core image can
be saved as a separate image. The TmaDB has a link to the
image server for each of the cores and results from the
analysis of the images are stored in the "core_expt_result"
table (Figure 2). Only the filenames of the images are
stored by TmaDB and the actual images are stored on the
image server.
Currently there are 18 TMA experiments stored in the
database although this number is set to rise. The number
of people whose clinical specimens have been analysed
on TMA is 1095 (April 2005). Most of this data has been
generated as part of clinical trials.
Utility and discussion
The MySQL relational database is interfaced with the
World Wide Web making the database user-friendly as
well as enabling access from remote locations for multiple
users at any time. The web site also enables users to sub-
mit and retrieve data from the database. The homepage
provides a brief background on TMA technology and out-
lines the advantages and disadvantages of the technique,
it also provides a menu for easy navigation of the web site.
A help page provides detailed explanations for each of the
menu links. A brief description is given below:
The search page allows users to retrieve data from the
database by searching with a specific keyword. Specific
searches can be performed for cases where the
"specimen_id" is already known by the user (Figure 4).
The "Display all records" link connects to a page contain-
ing all the tables in the database. Clicking on individual
table names fetches all the data contained in the particular
table. The "Database design" link, displays the ER diagram
(Figure 2). The "MySQL search" link is an html form that
enables the user to retrieve data from the database with
MySQL "select" statements. For security reasons, the user
only has permission to search the database but not write
to the database. However badly constructed MySQL
"select" statements with incorrect syntax will not be exe-
cuted and the MySQL error message will be displayed on
screen. In addition, the provision of SQL select facilities
could leave the database vulnerable to badly constructed
queries that would be damaging to performance but not
data, although this has not been a problem to date. TheBMC Bioinformatics 2005, 6:218 http://www.biomedcentral.com/1471-2105/6/218
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other four links on the menu are for inputting data into
the database. The "Submit TMA design" link allows the
user to upload a tab delimited text file which is then saved
into a directory on the server side and an email is sent
automatically to the curator who then checks the file to
make sure there are no errors and then the information is
loaded into the database automatically. The data is loaded
sequentially into the database beginning with the TMA
design ("Submit TMA design") then the specific details of
each of the cores on the TMA ("Submit core path data")
followed by experimental protocol and results ("Submit
experimental protocol and results") and finally the path-
ological data ("Submit block path report"). The file for-
mats for each of the files to be uploaded are shown on the
TmaDB homepage Figure 3
TmaDB homepage.BMC Bioinformatics 2005, 6:218 http://www.biomedcentral.com/1471-2105/6/218
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An example query of the database Figure 4
An example query of the database.BMC Bioinformatics 2005, 6:218 http://www.biomedcentral.com/1471-2105/6/218
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Web site. The final link on the menu connects to the
image server where all images for all TMAs are archived.
All files can also be uploaded in XML file format (the
schema for this is provided on the Web site). In addition
the output from all queries to the database can be dis-
played or downloaded as an XML file. The XML file format
is compatible with the data exchange specification devel-
oped by Berman et al. [4] in that we have adopted their
extensibility mechanism and therefore our instance docu-
ments are still valid under their exchange specifications.
The basic XML structure developed by Berman et al. [4]
has been extended with the aim of establishing a commu-
nity standard that is similar to MAGE-ML for microarray
databases [9].
The purpose of a central cancer TMA database is to pro-
vide a single repository for laboratory experimentalists to
store TMA experiments. Storage of all TMA experiments
will enable researchers to make correlations between the
intensity of staining of a specific antibody and the stage of
cancer, or between different types of cancers. The curation
of a database will also encourage researchers to report
results in a standard format thereby enabling comparisons
between experiments performed by different individuals.
An additional advantage of the database is to be able to
determine where a specimen block is stored or the person/
institution in possession of a specimen block of interest
for further experiments. Furthermore it is anticipated that
the database will also be used as a learning tool for
pathologists.
Further developments of the database include the addi-
tion of other information from different experiments
(such as cDNA microarray) on the same clinical specimen
used in the TMA experiment and allowing users to carry
out complex queries (see below).
An example of a complex query to the database:
Find all cases where specimens are stained with antibody
"p53" AND type of cancer is "colon" AND pT stage is "3".
Conclusion
The TmaDB provides a central repository for archiving all
aspects of TMA data. The relational database includes the
vast majority of the published Common Data Elements
for a TMA experiment. This will therefore enable efficient
data exchange as well as contributing to the establishment
of a standard for reporting TMA data analogous to MIAME
in the description of microarray data [10]. The database
design is adaptable such that pathological data from sev-
eral different types of cancer can be included in one
database.
It is anticipated that in addition to providing a resource
for archiving and querying TMA data TmaDB will also
enable large-scale analyses of TMA data.
Availability and requirements
Tmadb web site: http://www.bioinformatics.leeds.ac.uk/
tmadb.
The database and the software to upload files and query
the database are available under the GPL as a package for
installation on a local server [see 1].
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